Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001301469 | SCV001490639 | likely benign | Saldino-Mainzer syndrome | 2024-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003346440 | SCV004058938 | uncertain significance | Inborn genetic diseases | 2023-08-21 | criteria provided, single submitter | clinical testing | The c.2876G>A (p.R959Q) alteration is located in exon 23 (coding exon 21) of the IFT140 gene. This alteration results from a G to A substitution at nucleotide position 2876, causing the arginine (R) at amino acid position 959 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Dept Of Ophthalmology, |
RCV003888001 | SCV004704976 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV005014366 | SCV005642763 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-02-09 | criteria provided, single submitter | clinical testing |